![Kimimichi Obata](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Karriereverlauf von Kimimichi Obata
Ehemalige bekannte Positionen von Kimimichi Obata
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PRECISION SYSTEM SCIENCE CO., LTD. | Direktor/Vorstandsmitglied | 09.02.2010 | 16.11.2014 |
Corporate Officer/Principal | 09.02.2010 | 10.08.2011 | |
Universal Bio Research Co., Ltd. | Direktor/Vorstandsmitglied | 10.08.2011 | 16.11.2014 |
Precision System Science USA, Inc.
![]() Precision System Science USA, Inc. Medical SpecialtiesHealth Technology Part of Precision System Science Co., Ltd., Precision System Science USA, Inc. is a company that provides user-friendly technology for DNA extraction. The company is based in Pleasanton, CA. The company offers MagDEA® Dx LV Prefilled reagents cartridges for consistent and uniform magnetic bead-based nucleic acid extractions for large, 1 to 5 mL, sample volumes. Akihiro Furukawa has been the CEO of the company since 2017. | Direktor/Vorstandsmitglied | 10.08.2011 | 16.11.2014 |
Präsident | 10.08.2011 | 16.11.2014 |
Statistik
International
Japan | 3 |
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 3 |
Corporate Officer/Principal | 1 |
President | 1 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PRECISION SYSTEM SCIENCE CO., LTD. | Health Technology |
Private Unternehmen | 2 |
---|---|
Universal Bio Research Co., Ltd. | |
Precision System Science USA, Inc.
![]() Precision System Science USA, Inc. Medical SpecialtiesHealth Technology Part of Precision System Science Co., Ltd., Precision System Science USA, Inc. is a company that provides user-friendly technology for DNA extraction. The company is based in Pleasanton, CA. The company offers MagDEA® Dx LV Prefilled reagents cartridges for consistent and uniform magnetic bead-based nucleic acid extractions for large, 1 to 5 mL, sample volumes. Akihiro Furukawa has been the CEO of the company since 2017. | Health Technology |
- Börse
- Insiders
- Kimimichi Obata
- Erfahrung